Migraine Treatment Medication Zecuity Receives FDA Approval
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
1. “NuPathe’s Zecuity Approved by the FDA for the Acute Treatment of Migraine,” NuPathe Inc. press release, January 17, 2013, NuPathe.com. Available at: http://nupathe.mwnewsroom.com/press-releases/nupathe-s-zecuity-approved-by-the-fda-for-the-acut-nasdaq-path-975802?feed=All. Accessed January 17, 2013.